Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
Authors
Keywords
Alzheimer’s disease, Pioglitazone, Rosiglitazone, Tau hyperphosphorylation, Neuroinflammation, Thiazolidinediones
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 122, Issue 4, Pages 593-606
Publisher
Springer Nature
Online
2014-08-12
DOI
10.1007/s00702-014-1294-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
- (2014) David A. Drachman Alzheimers & Dementia
- Deregulation of brain insulin signaling in Alzheimer’s disease
- (2014) Yanxing Chen et al. Neuroscience Bulletin
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2013) Jessica Freiherr et al. CNS DRUGS
- PPAR-γ: Therapeutic Prospects in Parkinson's Disease
- (2013) Anna R. Carta CURRENT DRUG TARGETS
- Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice
- (2013) Yanxing Chen et al. MOLECULAR NEUROBIOLOGY
- Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology
- (2013) Panayiota Papadopoulos et al. PLoS One
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
- (2013) T. Wyss-Coray et al. Cold Spring Harbor Perspectives in Medicine
- Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
- (2012) Suzanne M. de la Monte Current Alzheimer Research
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPAR and ERK MAPK Signaling Pathways
- (2012) L. A. Denner et al. JOURNAL OF NEUROSCIENCE
- PPAR /RXR -Induced and CD36-Mediated Microglial Amyloid- Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
- (2012) M. Yamanaka et al. JOURNAL OF NEUROSCIENCE
- Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor- -Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
- (2012) S. Mandrekar-Colucci et al. JOURNAL OF NEUROSCIENCE
- A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer’s Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse)
- (2012) Yanxing Chen et al. MOLECULAR NEUROBIOLOGY
- Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD and wild-type mice
- (2012) F Masciopinto et al. Cell Death & Disease
- Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARs
- (2011) Barbara Brunmair et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice
- (2010) Julie Blanchard et al. ACTA NEUROPATHOLOGICA
- Alzheimer's disease, a multifactorial disorder seeking multitherapies
- (2010) Khalid Iqbal et al. Alzheimers & Dementia
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
- (2010) David S. Geldmacher et al. ARCHIVES OF NEUROLOGY
- Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status
- (2010) Jennifer Rodriguez-Rivera et al. BEHAVIOURAL BRAIN RESEARCH
- Targeting Tau Protein in Alzheimerʼs Disease
- (2010) Cheng-Xin Gong et al. DRUGS & AGING
- Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease
- (2010) Maria Jose Metcalfe et al. MOUNT SINAI JOURNAL OF MEDICINE
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- GSK3: A possible link between beta amyloid peptide and tau protein
- (2009) Félix Hernández et al. EXPERIMENTAL NEUROLOGY
- Brain glucose transporters,O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease
- (2009) Ying Liu et al. JOURNAL OF NEUROCHEMISTRY
- Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory Behaviors
- (2009) D. R. Marks et al. JOURNAL OF NEUROSCIENCE
- Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
- (2009) E M Toledo et al. MOLECULAR PSYCHIATRY
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
- (2009) Tomohiko Sato et al. NEUROBIOLOGY OF AGING
- Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer’s disease mouse model
- (2008) Luis Escribano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
- (2008) Ying Liu et al. FEBS LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started